
### [MONDO:0004975](http://purl.obolibrary.org/obo/MONDO_0004975)
**Label:** Alzheimers disease

**Subclasses:** [MONDO:0012153](http://purl.obolibrary.org/obo/MONDO_0012153) (AD9), [MONDO:0014036](http://purl.obolibrary.org/obo/MONDO_0014036) (Alzheimer's disease 17), [MONDO:0011194](http://purl.obolibrary.org/obo/MONDO_0011194) (Alzheimer disease 5), [MONDO:0012344](http://purl.obolibrary.org/obo/MONDO_0012344) (Alzheimer's disease 11), [MONDO:0012630](http://purl.obolibrary.org/obo/MONDO_0012630) (Alzheimer's disease 13), [MONDO:0012321](http://purl.obolibrary.org/obo/MONDO_0012321) (Alzheimer's disease 10), [MONDO:0011561](http://purl.obolibrary.org/obo/MONDO_0011561) (Alzheimer's disease 6), [MONDO:0014265](http://purl.obolibrary.org/obo/MONDO_0014265) (Alzheimer's disease 18), [MONDO:0015140](http://purl.obolibrary.org/obo/MONDO_0015140) (early-onset autosomal dominant Alzheimer disease), [MONDO:0012609](http://purl.obolibrary.org/obo/MONDO_0012609) (Alzheimer's disease 12), [MONDO:0011913](http://purl.obolibrary.org/obo/MONDO_0011913) (Alzheimer's disease 3), [MONDO:0011743](http://purl.obolibrary.org/obo/MONDO_0011743) (Alzheimer's disease 4), [MONDO:0007089](http://purl.obolibrary.org/obo/MONDO_0007089) (Alzheimer's disease 2), [MONDO:0010422](http://purl.obolibrary.org/obo/MONDO_0010422) (Alzheimer's disease 16), [MONDO:0011401](http://purl.obolibrary.org/obo/MONDO_0011401) (Alzheimer disease without Neurofibrillary tangles), [MONDO:0007088](http://purl.obolibrary.org/obo/MONDO_0007088) (Alzheimer disease type 1), [MONDO:0010783](http://purl.obolibrary.org/obo/MONDO_0010783) (Alzheimer disease, susceptibility to, mitochondrial), [MONDO:0012632](http://purl.obolibrary.org/obo/MONDO_0012632) (Alzheimer's disease 15), [MONDO:0012631](http://purl.obolibrary.org/obo/MONDO_0012631) (Alzheimer's disease 14), [MONDO:0011647](http://purl.obolibrary.org/obo/MONDO_0011647) (Alzheimer's disease 7), [MONDO:0014316](http://purl.obolibrary.org/obo/MONDO_0014316) (Alzheimer's disease 19), [MONDO:0011513](http://purl.obolibrary.org/obo/MONDO_0011513) (Alzheimer disease, familial early-onset, with Coexisting amyloid and prion pathology), [MONDO:0011777](http://purl.obolibrary.org/obo/MONDO_0011777) (Alzheimer's disease 8), 

**Corr. equiv. classes:** [OMIM:606889](http://purl.obolibrary.org/obo/OMIM_606889), [OMIM:605526](http://purl.obolibrary.org/obo/OMIM_605526), [OMIM:615080](http://purl.obolibrary.org/obo/OMIM_615080), [OMIM:607116](http://purl.obolibrary.org/obo/OMIM_607116), [OMIM:609636](http://purl.obolibrary.org/obo/OMIM_609636), [OMIM:607822](http://purl.obolibrary.org/obo/OMIM_607822), [OMIM:615590](http://purl.obolibrary.org/obo/OMIM_615590), [OMIM:502500](http://purl.obolibrary.org/obo/OMIM_502500), [OMIM:608907](http://purl.obolibrary.org/obo/OMIM_608907), [OMIM:300756](http://purl.obolibrary.org/obo/OMIM_300756), [OMIM:611073](http://purl.obolibrary.org/obo/OMIM_611073), [OMIM:611152](http://purl.obolibrary.org/obo/OMIM_611152), [OMIM:609790](http://purl.obolibrary.org/obo/OMIM_609790), [OMIM:611154](http://purl.obolibrary.org/obo/OMIM_611154), [OMIM:611155](http://purl.obolibrary.org/obo/OMIM_611155), [Orphanet:1020](http://www.orpha.net/ORDO/Orphanet_1020), [OMIM:615711](http://purl.obolibrary.org/obo/OMIM_615711), [OMIM:606187](http://purl.obolibrary.org/obo/OMIM_606187), [OMIM:104310](http://purl.obolibrary.org/obo/OMIM_104310), [OMIM:605055](http://purl.obolibrary.org/obo/OMIM_605055), [OMIM:604154](http://purl.obolibrary.org/obo/OMIM_604154), [OMIM:104300](http://purl.obolibrary.org/obo/OMIM_104300), [OMIM:602096](http://purl.obolibrary.org/obo/OMIM_602096), 

**Class expressions from DL-Learner:**

- [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) 67.00%
- [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 65.22%
- [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 65.22%
- [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 65.22%
- [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 65.22%
- [HP:0002060](http://purl.obolibrary.org/obo/HP_0002060) (Abnormality of the cerebrum) and [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) 65.22%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) 65.22%
- [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 65.22%
- [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 65.22%
- [HP:0002060](http://purl.obolibrary.org/obo/HP_0002060) (Abnormality of the cerebrum) and [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 65.22%
- [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 64.53%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) 63.04%
- [HP:0000726](http://purl.obolibrary.org/obo/HP_0000726) (Dementia) and [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) 63.04%
- [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 63.04%
- [HP:0002511](http://purl.obolibrary.org/obo/HP_0002511) (Alzheimer disease) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 63.04%


